My NCBI | Sign In
RSS Settings
  • Search: Sankatsing Sanjay[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 14

    1.

    Mycophenolate mofetil inhibits T-cell proliferation in kidney transplant recipients without lowering intracellular dGTP and GTP.

    Sankatsing SU, Prins JM, Yong SL, Roelofsen J, van Kuilenburg AB, Kewn S, Back DJ, Bemelman FJ, ten Berge IJ.

    Transpl Int. 2008 Nov;21(11):1066-71.PMID: 18699845 [PubMed - indexed for MEDLINE]Related articles

    2.

    Diffuse interstitial pulmonary opacities induced by nevirapine.

    Sankatsing SU, Schouten WE.

    AIDS. 2007 Sep 12;21(14):1993-4. No abstract available. PMID: 17721119 [PubMed - indexed for MEDLINE]Related articles

    3.

    Antiviral activity of HIV type 1 protease inhibitors nelfinavir and indinavir in vivo is not influenced by P-glycoprotein activity on CD4+ T cells.

    Sankatsing SU, Cornelissen M, Kloosterboer N, Crommentuyn KM, Bosch TM, Mul FP, Jurriaans S, Huitema AD, Beijnen JH, Lange JM, Prins JM, Schuitemaker H.

    AIDS Res Hum Retroviruses. 2007 Jan;23(1):19-27.PMID: 17263628 [PubMed - indexed for MEDLINE]Related articles

    4.

    Short communication: No detrimental immunological effects of mycophenolate mofetil and HAART in treatment-naive acute and chronic HIV-1-infected patients.

    Vrisekoop N, Sankatsing SU, Jansen CA, Roos MT, Otto SA, Schuitemaker H, Lange JM, Prins JM, Miedema F.

    AIDS Res Hum Retroviruses. 2005 Dec;21(12):991-6.PMID: 16379601 [PubMed - indexed for MEDLINE]Related articles

    5.

    Population pharmacokinetics of indinavir alone and in combination with ritonavir in HIV-1-infected patients.

    Kappelhoff BS, Huitema AD, Sankatsing SU, Meenhorst PL, Van Gorp EC, Mulder JW, Prins JM, Beijnen JH.

    Br J Clin Pharmacol. 2005 Sep;60(3):276-86.PMID: 16120066 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Analysis of the effect of highly active antiretroviral therapy during acute HIV-1 infection on HIV-specific CD4 T cell functions.

    Jansen CA, De Cuyper IM, Steingrover R, Jurriaans S, Sankatsing SU, Prins JM, Lange JM, van Baarle D, Miedema F.

    AIDS. 2005 Jul 22;19(11):1145-54.PMID: 15990567 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effect of mycophenolate mofetil on the pharmacokinetics of antiretroviral drugs and on intracellular nucleoside triphosphate pools.

    Sankatsing SU, Hoggard PG, Huitema AD, Sparidans RW, Kewn S, Crommentuyn KM, Lange JM, Beijnen JH, Back DJ, Prins JM.

    Clin Pharmacokinet. 2004;43(12):823-32. Erratum in: Clin Pharmacokinet. 2005;44(12):1246. PMID: 15355127 [PubMed - indexed for MEDLINE]Related articles

    8.

    Highly active antiretroviral therapy with or without mycophenolate mofetil in treatment-naive HIV-1 patients.

    Sankatsing SU, Jurriaans S, van Swieten P, van Leth F, Cornelissen M, Miedema F, Lange JM, Schuitemaker H, Prins JM.

    AIDS. 2004 Sep 24;18(14):1925-31.PMID: 15353978 [PubMed - indexed for MEDLINE]Related articles

    9.

    HIV-1 seroreversion in an HIV-1-seropositive patient treated during acute infection with highly active antiretroviral therapy and mycophenolate mofetil.

    Jurriaans S, Sankatsing SU, Prins JM, Schuitemaker H, Lange J, Van Der Kuyl AC, Cornelissen M.

    AIDS. 2004 Jul 23;18(11):1607-8. No abstract available. PMID: 15238784 [PubMed - indexed for MEDLINE]Related articles

    10.

    Is the male genital tract really a sanctuary site for HIV? Arguments that it is not.

    Lowe SH, Sankatsing SU, Repping S, van der Veen F, Reiss P, Lange JM, Prins JM.

    AIDS. 2004 Jul 2;18(10):1353-62. Review. No abstract available. PMID: 15199311 [PubMed - indexed for MEDLINE]Related articles

    11.

    P glycoprotein in human immunodeficiency virus type 1 infection and therapy.

    Sankatsing SU, Beijnen JH, Schinkel AH, Lange JM, Prins JM.

    Antimicrob Agents Chemother. 2004 Apr;48(4):1073-81. Review. No abstract available. PMID: 15047504 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    TMC125 exerts similar initial antiviral potency as a five-drug, triple class antiretroviral regimen.

    Sankatsing SU, Weverling GJ, Peeters M, van't Klooster G, Gruzdev B, Rakhmanova A, Danner SA, Jurriaans S, Prins JM, Lange JM.

    AIDS. 2003 Dec 5;17(18):2623-7.PMID: 14685056 [PubMed - indexed for MEDLINE]Related articles

    13.

    Dynamics of the pool of infected resting CD4 HLA-DR- T lymphocytes in patients who started a triple class five-drug antiretroviral regimen during primary HIV-1 infection.

    Sankatsing SU, van Praag RM, van Rij RP, Rientsma R, Jurriaans S, Lange JM, Prins JM, Schuitemaker H.

    Antivir Ther. 2003 Apr;8(2):137-42.PMID: 12741626 [PubMed - indexed for MEDLINE]Related articles

    14.

    Limited penetration of lopinavir into seminal plasma of HIV-1-infected men.

    Sankatsing SU, Droste J, Burger D, Van Praag RM, Jurriaans S, Lange JM, Prins JM.

    AIDS. 2002 Aug 16;16(12):1698-700. No abstract available. PMID: 12172099 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    2 free full-text articles in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity